HUP0300326A3 - 4-oxo-1,4-dihydro-3-cinnolinecarboxamides of antiviral effect their use and pharmaceutical compositions containing them - Google Patents
4-oxo-1,4-dihydro-3-cinnolinecarboxamides of antiviral effect their use and pharmaceutical compositions containing themInfo
- Publication number
- HUP0300326A3 HUP0300326A3 HU0300326A HUP0300326A HUP0300326A3 HU P0300326 A3 HUP0300326 A3 HU P0300326A3 HU 0300326 A HU0300326 A HU 0300326A HU P0300326 A HUP0300326 A HU P0300326A HU P0300326 A3 HUP0300326 A3 HU P0300326A3
- Authority
- HU
- Hungary
- Prior art keywords
- cinnolinecarboxamides
- dihydro
- oxo
- pharmaceutical compositions
- compositions containing
- Prior art date
Links
- IJAVOENDLHVSER-UHFFFAOYSA-N 4-oxo-1h-cinnoline-3-carboxamide Chemical class C1=CC=CC2=C(O)C(C(=O)N)=NN=C21 IJAVOENDLHVSER-UHFFFAOYSA-N 0.000 title 1
- 230000000840 anti-viral effect Effects 0.000 title 1
- 239000008194 pharmaceutical composition Substances 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/20—Antivirals for DNA viruses
- A61P31/22—Antivirals for DNA viruses for herpes viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D237/00—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings
- C07D237/26—Heterocyclic compounds containing 1,2-diazine or hydrogenated 1,2-diazine rings condensed with carbocyclic rings or ring systems
- C07D237/28—Cinnolines
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/06—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US19129100P | 2000-03-21 | 2000-03-21 | |
| PCT/US2001/005811 WO2001070706A2 (en) | 2000-03-21 | 2001-03-15 | 4-oxo-1,4-dihydro-3-cinnolinecarboxamides as antiviral agents |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| HUP0300326A2 HUP0300326A2 (hu) | 2003-07-28 |
| HUP0300326A3 true HUP0300326A3 (en) | 2003-09-29 |
Family
ID=22704885
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HU0300326A HUP0300326A3 (en) | 2000-03-21 | 2001-03-15 | 4-oxo-1,4-dihydro-3-cinnolinecarboxamides of antiviral effect their use and pharmaceutical compositions containing them |
Country Status (28)
| Country | Link |
|---|---|
| US (1) | US6624160B2 (hu) |
| EP (1) | EP1265873B1 (hu) |
| JP (1) | JP2003528087A (hu) |
| KR (1) | KR20020081479A (hu) |
| CN (1) | CN1406228A (hu) |
| AR (1) | AR027978A1 (hu) |
| AT (1) | ATE252086T1 (hu) |
| AU (1) | AU2001247224A1 (hu) |
| BR (1) | BR0109487A (hu) |
| CA (1) | CA2400000A1 (hu) |
| CZ (1) | CZ20023141A3 (hu) |
| DE (1) | DE60100999T2 (hu) |
| DK (1) | DK1265873T3 (hu) |
| EA (1) | EA200201002A1 (hu) |
| EE (1) | EE200200541A (hu) |
| ES (1) | ES2208581T3 (hu) |
| HK (1) | HK1052694A1 (hu) |
| HU (1) | HUP0300326A3 (hu) |
| IL (1) | IL151787A0 (hu) |
| MX (1) | MXPA02009251A (hu) |
| NO (1) | NO20024502L (hu) |
| NZ (1) | NZ521524A (hu) |
| PL (1) | PL357443A1 (hu) |
| PT (1) | PT1265873E (hu) |
| SI (1) | SI1265873T1 (hu) |
| SK (1) | SK12102002A3 (hu) |
| WO (1) | WO2001070706A2 (hu) |
| ZA (1) | ZA200207540B (hu) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PE20011349A1 (es) * | 2000-06-16 | 2002-01-19 | Upjohn Co | 1-aril-4-oxo-1,4-dihidro-3-quinolincarboxamidas como agentes antivirales |
| WO2014070976A1 (en) * | 2012-11-03 | 2014-05-08 | Boehringer Ingelheim International Gmbh | Inhibitors of cytomegalovirus |
| CA3112326A1 (en) | 2018-09-12 | 2020-03-19 | Novartis Ag | Antiviral pyridopyrazinedione compounds |
| CN114667285A (zh) | 2019-09-26 | 2022-06-24 | 诺华股份有限公司 | 抗病毒吡唑并吡啶酮化合物 |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB8513639D0 (en) | 1985-05-30 | 1985-07-03 | Ici America Inc | Cinnoline compounds |
| GB8702288D0 (en) * | 1987-02-02 | 1987-03-11 | Erba Farmitalia | Cinnoline-carboxamides |
| PT841929E (pt) | 1995-08-02 | 2003-09-30 | Darwin Discovery Ltd | Quinolonas e sua utilizacao terapeutica |
| AU695132B2 (en) | 1995-08-02 | 1998-08-06 | Darwin Discovery Limited | Quinolones and their therapeutic use |
| BR9814323A (pt) | 1997-12-22 | 2004-06-29 | Upjohn Co | 4-hidroxiquinolina-3-carboxamidas e hidrazidas como agentes antiviróticos |
| AU763636C (en) | 1998-01-29 | 2004-05-27 | Daiichi Asubio Pharma Co., Ltd. | 1-cycloalkyl-1,8-naphthyridin-4-one derivatives with phosphodiesterase IV inhibitory activity |
-
2001
- 2001-03-15 AU AU2001247224A patent/AU2001247224A1/en not_active Abandoned
- 2001-03-15 PL PL01357443A patent/PL357443A1/xx not_active Application Discontinuation
- 2001-03-15 NZ NZ521524A patent/NZ521524A/en unknown
- 2001-03-15 EE EEP200200541A patent/EE200200541A/xx unknown
- 2001-03-15 KR KR1020027012466A patent/KR20020081479A/ko not_active Application Discontinuation
- 2001-03-15 IL IL15178701A patent/IL151787A0/xx unknown
- 2001-03-15 SK SK1210-2002A patent/SK12102002A3/sk unknown
- 2001-03-15 PT PT01920138T patent/PT1265873E/pt unknown
- 2001-03-15 ES ES01920138T patent/ES2208581T3/es not_active Expired - Lifetime
- 2001-03-15 JP JP2001568916A patent/JP2003528087A/ja active Pending
- 2001-03-15 CN CN01805756A patent/CN1406228A/zh active Pending
- 2001-03-15 CA CA002400000A patent/CA2400000A1/en not_active Abandoned
- 2001-03-15 EP EP01920138A patent/EP1265873B1/en not_active Expired - Lifetime
- 2001-03-15 CZ CZ20023141A patent/CZ20023141A3/cs unknown
- 2001-03-15 EA EA200201002A patent/EA200201002A1/ru unknown
- 2001-03-15 AT AT01920138T patent/ATE252086T1/de not_active IP Right Cessation
- 2001-03-15 WO PCT/US2001/005811 patent/WO2001070706A2/en active IP Right Grant
- 2001-03-15 DE DE60100999T patent/DE60100999T2/de not_active Expired - Fee Related
- 2001-03-15 SI SI200130046T patent/SI1265873T1/xx unknown
- 2001-03-15 US US09/808,836 patent/US6624160B2/en not_active Expired - Fee Related
- 2001-03-15 HU HU0300326A patent/HUP0300326A3/hu unknown
- 2001-03-15 MX MXPA02009251A patent/MXPA02009251A/es active IP Right Grant
- 2001-03-15 DK DK01920138T patent/DK1265873T3/da active
- 2001-03-15 BR BR0109487-4A patent/BR0109487A/pt not_active IP Right Cessation
- 2001-03-20 AR ARP010101303A patent/AR027978A1/es unknown
-
2002
- 2002-09-19 ZA ZA200207540A patent/ZA200207540B/en unknown
- 2002-09-20 NO NO20024502A patent/NO20024502L/no not_active Application Discontinuation
-
2003
- 2003-07-09 HK HK03104900.8A patent/HK1052694A1/zh unknown
Also Published As
| Publication number | Publication date |
|---|---|
| CN1406228A (zh) | 2003-03-26 |
| EA200201002A1 (ru) | 2003-02-27 |
| PL357443A1 (en) | 2004-07-26 |
| DE60100999T2 (de) | 2004-09-02 |
| CA2400000A1 (en) | 2001-09-27 |
| SK12102002A3 (sk) | 2003-03-04 |
| MXPA02009251A (es) | 2004-04-05 |
| ZA200207540B (en) | 2003-12-19 |
| US20020045619A1 (en) | 2002-04-18 |
| EE200200541A (et) | 2004-04-15 |
| WO2001070706A3 (en) | 2002-05-10 |
| IL151787A0 (en) | 2003-04-10 |
| EP1265873B1 (en) | 2003-10-15 |
| SI1265873T1 (en) | 2004-02-29 |
| WO2001070706A2 (en) | 2001-09-27 |
| CZ20023141A3 (cs) | 2003-02-12 |
| KR20020081479A (ko) | 2002-10-26 |
| NO20024502D0 (no) | 2002-09-20 |
| NZ521524A (en) | 2004-04-30 |
| JP2003528087A (ja) | 2003-09-24 |
| ES2208581T3 (es) | 2004-06-16 |
| HK1052694A1 (zh) | 2003-09-26 |
| AU2001247224A1 (en) | 2001-10-03 |
| HUP0300326A2 (hu) | 2003-07-28 |
| BR0109487A (pt) | 2003-06-10 |
| PT1265873E (pt) | 2004-03-31 |
| NO20024502L (no) | 2002-11-20 |
| DK1265873T3 (da) | 2004-02-16 |
| EP1265873A2 (en) | 2002-12-18 |
| DE60100999D1 (en) | 2003-11-20 |
| AR027978A1 (es) | 2003-04-23 |
| US6624160B2 (en) | 2003-09-23 |
| ATE252086T1 (de) | 2003-11-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HUP0301146A3 (en) | 2-chlor-5-nitrophenyl carboxamide derivatives, pharmaceutical compositions containing them and their use | |
| HUP0204514A3 (en) | Pyridinylimidazoles, pharmaceutical compositions containing them and their use | |
| HUP0400837A3 (en) | 2-phenyl-thiazole derivatives, their use and pharmaceutical compositions containing them | |
| HUP0204474A3 (en) | 1h-imidazopyridine derivatives, pharmaceutical compositions containing them and their use | |
| HUP0400784A3 (en) | Bicyclic heterocondensated pyrrolcarboxamide derivatives, their use and pharmaceutical compositions containing them | |
| HUP0301722A3 (en) | Pyrimidine derivatives, pharmaceutical compositions containing them and their use | |
| HUP0400467A3 (en) | 2-iminopyrrolidine derivatives, pharmaceutical compositions containing them and their use | |
| HUP0200308A3 (en) | Quinolinecarboxamides as antiviral agents, pharmaceutical compositions containing them and their use | |
| HUP0301573A3 (en) | Substituted arylpyrazines, pharmaceutical compositions containing them and their use | |
| HUP0401567A3 (en) | Novel 4,5-dyhydro-1h-pyrazole derivatives having cb1-antagonistic activity, their use and pharmaceutical compositions containing them | |
| HUP0401718A3 (en) | Bicyclic oxopyridine and oxopyrimidine derivatives, their use and pharmaceutical compositions containing them | |
| PT1296974E (pt) | Derivados 2-cianopirrolidina e sua utilização como medicamentos | |
| HUP0402566A3 (en) | C-5 modified indazolylamino pyrrolotriazines, their use and pharmaceutical compositions containing them | |
| HUP0303082A3 (en) | Substituted indoleoxoacetic piperazine derivatives, pharmaceutical compositions containing them and their antiviral use | |
| HUP0300207A3 (en) | 1,2,3,4-tetrahydroisquinoline derivatives, pharmaceutical compositions containing them and their preparation processes | |
| HUP0204101A3 (en) | 3-aminoquinazolin-2,4-dione antibacterial agents, pharmaceutical compositions containing them and their use | |
| HUP0204081A3 (en) | 4-pyrimidinyl-n-acyl-l-phenylalanines, pharmaceutical compositions containing them and their use | |
| HUP0303410A3 (en) | Antimicrobial quinolones, pharmaceutical compositions containing them and their use | |
| HUP0300909A3 (en) | 2-guanidino-4-arylchinazolines as nhe-3 inhibitors, pharmaceutical compositions containing them and their use | |
| HUP0400967A3 (en) | Substituted 2-anilino-benzimidazoles, their use and pharmaceutical compositions containing them | |
| HUP0203194A3 (en) | Phenylpiperazines, pharmaceutical compositions containing them and their use | |
| HUP0203735A3 (en) | 4-pyridinyl-n-acyl-l-phenylalanines, pharmaceutical compositions containing them and their use | |
| HUP0500024A3 (en) | 6-aminomorphinane derivatives, their use and pharmaceutical compositions containing them | |
| HUP0401403A3 (en) | 2,4-diaminothiazole derivatives, their use and pharmaceutical compositions containing them | |
| HUP0400179A3 (en) | 2,5-diarylpyrazines, 2,5-diarylpyridines and 2,5-diarylpyrimidines, their use and pharmaceutical compositions containing them |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FD9A | Lapse of provisional protection due to non-payment of fees |